The traditional healthcare professional (HCP) target list model, long used in pharmaceutical commercial strategy, is becoming obsolete. This static approach fails to account for the dynamic nature of the market, where HCP priorities can shift rapidly due to new information or changing access conditions. Instead of focusing on 'who' to target, the industry needs to shift towards identifying 'why now' and 'what to do' at critical decision moments. Artificial intelligence can help identify these shifts, but its true value lies in creating learning systems that improve future decisions by analyzing both successful and unsuccessful actions, thereby strengthening human judgment rather than replacing it. AI
IMPACT Suggests a shift towards AI-powered dynamic decision-making in pharma sales, moving beyond static targeting.
RANK_REASON The item is an opinion piece by a named author discussing a shift in industry strategy, not a direct product release or research finding.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →